Role of endothelin in modulation of heart rate variability in patients with decompensated heart failure

PACE - Pacing and Clinical Electrophysiology

Volumn 24, Issue 11, 2001, Pages 1607-1615

  Aronson, Doron ^a,b   Mittleman, Murray A ^a,b   Burger, Andrew J ^a,b,c  

^a RAMBAM MEDICAL CENTER   (Israel)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Congestive heart failure; Endothelin; Heart rate variability

Indexed keywords

ALDOSTERONE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN 1; NORADRENALIN; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CONGESTIVE HEART FAILURE; FEMALE; HEART RATE VARIABILITY; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; MODULATION; NEUROENDOCRINE SYSTEM; PLASMA RENIN ACTIVITY;

EID: 0035162906     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2001.01607.x     Document Type: Article

References (47)

1. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunstion (SOLVD)
2. Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure
3. Sympathetic predominance followed by functional denervation in the progression of chronic heart failure
4. The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure
5. Integrated cardiac, renal, and endocrine actions of endothelin
6. Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure
7. Endothelin in human congestive heart failure
8. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure
9. Relation between endothelin-1 spillover in the lungs and pulmonary vascular resistance in patients with chronic heart failure
10. Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure
11. Heart rate variability in idiopathic dilated cardiomyopathy: Characteristics and prognostic value
12. Ability of heart rate variability to predict prognosis in patients with advanced congestive heart failure
13. Prospective study of heart rate variability and mortality in chronic heart failure: Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-HEART)
14. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
15. Ventilatory response to exercise correlates with impaired heart rate variability in patients with chronic congestive heart failure
16. Heart rate variability is independent of age, gender, and race in congestive heart failure with a recent acute exacerbation
17. Clinical, hemodynamic and sympathetic neural correlates of heart rate variability in congestive heart failure
18. Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure
19. Physiological role of brain endothelin in the central autonomic control: From neuron to knockout mouse
20. Postganglionic sympathetic neurons express endothelin
21. Chronic endothelin blockade in dogs with pacing-induced heart failure: Possible modulation of sympathoexcitation
22. Strategies for determination of serum or plasma norepinephrine by reverse-phase liquid chromatography
23. A sensitive sandwich-enzyme immunoassay for human endothelin
24. Heart rate variability: Standards of measurement, physiological interpretation and clinical use
25. Efficient estimation of the heart period power spectrum suitable for physiologic or pharmacologic studies
26. RR variability in healthy, middle-aged persons compared with patients with chronic coronary heart disease or recent acute myocardial infarction
27. Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: A report from the Registry of Studies of Left Ventricular Dysfunction
28. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the Studies of Left Ventricular Dysfunction (SOLVD)
29. Short- and long-term reproducibility of heart rate variability in patients with long-standing type I diabetes mellitus
30. Arterial baroreflex modulation of heart rate in chronic heart failure: Clinical and hemodynamic correlates and prognostic implications
31. Absence of low-frequency variability of sympathetic nerve activity in severe heart failure
32. Mechanisms underlying very-low-frequency RR-interval oscillations in humans
33. Plasma endothelin in chronic heart failure
34. The role of cytokines in the failing human heart
35. Correlations among time and frequency domain measures of heart period variability two weeks after acute myocardial infarction
36. Relation of ultra-low frequency heart rate variability to the clinical course of chronic aortic regurgitation
37. Prognostic value and physiological correlates of heart rate variability in chronic severe mitral regurgitation
38. Relation of the reninangiotensin-aldosterone system to clinical state in congestive heart failure
39. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure
40. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure
41. Central effects of endothelin and its antagonists on sympathetic and cardiovascular regulation in SHR-SP
42. Role of ET(A) and ET(B) receptors in endothelin-1-induced adrenal catecholamine secretion in vivo
43. Inhibition by endothelin-1 of cholinergic nerve-mediated acetylcholine release and contraction in sheep isolated trachea
44. Endothelin-1 mediated inhibition of the acetylcholine-activated potassium current from rabbit isolated atrial cardiomyocytes
45. Suppression of baroreceptor discharge by endothelin at high carotid sinus pressure
46. Long-term carvedilol therapy increases parasympathetic nervous activity in chronic congestive heart failure
47. Physical activity influences heart rate variability and very-low-frequency components in Holter electrocardiograms